1-183103530-T-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000258341.5(LAMC1):āc.621T>Gā(p.Asp207Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000175 in 1,613,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000258341.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMC1 | NM_002293.4 | c.621T>G | p.Asp207Glu | missense_variant | 2/28 | ENST00000258341.5 | NP_002284.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMC1 | ENST00000258341.5 | c.621T>G | p.Asp207Glu | missense_variant | 2/28 | 1 | NM_002293.4 | ENSP00000258341 | P1 | |
LAMC1 | ENST00000484114.2 | c.-265T>G | 5_prime_UTR_variant | 2/4 | 3 | ENSP00000473583 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 250868Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135528
GnomAD4 exome AF: 0.000181 AC: 264AN: 1461628Hom.: 0 Cov.: 34 AF XY: 0.000157 AC XY: 114AN XY: 727070
GnomAD4 genome AF: 0.000118 AC: 18AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.621T>G (p.D207E) alteration is located in exon 2 (coding exon 2) of the LAMC1 gene. This alteration results from a T to G substitution at nucleotide position 621, causing the aspartic acid (D) at amino acid position 207 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at